Cary Bleasdale

Cary Bleasdale is a 13 year veteran of the medical device regulatory space and a consultant for both the Fortune 100 and startups. With over a decade of experience in working with the FDA, he is also an expert in worldwide regulatory affairs, with a focus on the EU. His background includes a decade of work with SaMD and AI medical devices. These include, most recently, AI models used for targeted molecular biotherapy. His company, James & Thomas Meditech Consulting, offers regulatory strategy and submission support.